monitor toxicities when treating breast cancer with immunotherapy
Published 4 years ago • 101 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
6:01
immunotherapy for triple-negative breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
2:04
dr. mayer on toxicities associated with therapies for er breast cancer
-
0:17
unlocking immunotherapy for breast cancer
-
1:35
dr. pat whitworth discusses treating breast cancer with chemotherapy
-
2:08
dr. adams on immunotherapy in triple-negative breast cancer
-
1:48
the role of immunotherapy for metastatic breast cancer or relapse
-
1:12
dr. mittendorf discusses immunotherapy efforts in breast cancer
-
5:55
how to understand immunotherapy for breast cancer treatment
-
6:06
immunotherapy in breast cancer
-
11:40
toxicities associated with anti–pd-1 immunotherapy
-
21:00
precision medicine in metastatic triple negative breast cancer
-
5:32
first-line er-positive metastatic breast cancer treatments
-
3:21
severe toxicity to aromatase inhibitors for breast cancer
-
34:26
how personalized immunotherapy can help combat metastatic breast cancer
-
8:32
immunotherapy for triple-negative breast cancer
-
5:49
neoadjuvant treatment for triple-negative breast cancer
-
2:05
immunotherapy in breast cancer
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy